IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Celldex Therapeutics Inc New

CUSIP: 15117B103 | 444 institutional holders

Quarters

Q3 2023Q2 2020Q1 2020Q4 2019Q3 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2023

Byrne Asset Management LLC86
0.0% of portfolio›$2.0K
StyleTurnoverLocationFiled
Byrne Asset Management LLC
86$2.0K0.0%CoreLowKingston, NJ2023-10-31